Skip to main content
Egyptian Journal of Radiology and Nuclear Medicine
Fig. 4 | Egyptian Journal of Radiology and Nuclear Medicine

Fig. 4

From: "Sinopharm", "Oxford-AstraZeneca", and "Pfizer-BioNTech" COVID-19 vaccinations: testing efficacy using lung CT-volumetry with comparative analysis of variance (ANOVA)

Fig. 4

A 43-year-old female patient with negative past medical history and had received “Oxford-AstraZeneca” vaccine then got COVID-19 infection. A, B Axial chest CT cuts (lung window) showed bilateral mainly peripheral located ground-glass pneumonic patches and fine atelectatic bands. C CT-Volumetry of the pathological lung parts averages 904 cc. D CT-Volumetry of total lung volume averages 5771 cc. So, only 16% of the lung parenchyma was diseased (Score 1)

Back to article page